A Study of PM1022 in Patients With Advanced Tumors

Clinical trial NCT05867771 · UNKNOWN

Trial details

NCT number: NCT05867771
Sponsor: Biotheus Inc.
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Tumors

Start date: 2022-04-11
Primary completion: 2024-04-10
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.